Dr. Jennifer Vena and Dr. Rachel Murphy at #CCRC2023

Dr. Jennifer Vena and Dr. Rachel Murphy will be attending the Canadian Cancer Research Conference from Alberta and British Columbia. Dr. Vena is the Scientific Director of Alberta’s Tomorrow Project and a Research Scientist at CancerControl Alberta with Alberta Health Services. Dr. Vena’s research interests focus on lifestyle behaviours and prevention of cancer and chronic diseases, as well as population cohort science, and involves scientific, strategic, and operational elements. Dr. Vena will be presenting a poster on the dietary screener that was developed to assess adherence to Canada’s Food Guide and how it could be used for cancer prevention research. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST.  Dr. Murphy is a Senior Scientist at BC Cancer and an Associate Professor at the School of Population and Public Health at the University of British Columbia. Dr. Murphy’s research interests include reducing the risk of cancer through modifiable lifestyle factors, with a focus on healthy eating and body weight. Additional interests include older adults and other populations with increased risk of cancer, knowledge translation of nutrition evidence, and metabolomics; the study of small molecules in biological systems that may provide insight on pathways linking lifestyle factors and disease.   Dr. Murphy will be presenting at and chairing a session with Patient Partner, Rachelle Bould on Reducing Your Risk of Cancer on Tuesday, November 14th at 9:00am AST. The presenters include:  Dr. Rachel Murphy (University of British Columbia, BC Cancer) speaking about diet, geographies and risk for cancer  Dr. Laura Struik (University of British Columbia) speaking about factors influencing youth vaping uptake  Dr. Paul Demers (Occupational Cancer Research Centre, Ontario Health) speaking about the etiology of rare cancers in a large occupational cohort  Umaima Abbas (University of Western Ontario) speaking about the effectiveness and cost-effectiveness of population level policies to reduce alcohol use   

Ethan Ring & Dr. Cindy Feng at #CCRC2023

Ethan Ring is a third year Masters student in the Department of Community Health and Epidemiology at Dalhousie University. His research interests include environmental carcinogens and their role in cancer development.   Ethan will be presenting a poster at the Canadian Cancer Research Conference from his graduate work on the association between potential asbestos exposure and breast cancer risk in Atlantic Canada. This work utilized baseline and follow-up data from 8,160 female Atlantic PATH participants and is part of a larger study led by Dr. Cindy Feng on Predictive Modeling and Geographical Analysis of Cancer Incidence in the Atlantic Region.  Ethan’s Master’s supervisor is Dr. Cindy Feng, Associate Professor, Department of Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Affiliate Scientist (Research), Nova Scotia Health, and Affiliate Scientist, Beatrice Hunter Cancer Research Institute. Additional committee members include Dr. Leah Cahill, Dr. Nathalie St-Jacques, Dr. Ellen Sweeney, and Dr. Robin Urquhart.   Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST. 

CanPath at #CCRC2023: Canada’s Largest Population Laboratory for Cancer Research

Dr. Philip Awadalla, Scientific Director of CanPath, and Patient Partner/Atlantic PATH participant, Pauline McIntyre, will chair a panel at the Canadian Cancer Research Conference, “CanPath: Canada’s Largest Population Laboratory for Cancer Research” on Monday, November 13th at 11:40 AST. Presenters include Dr. Dylan O’Sullivan, Dr. Samina Abidi, Dr. Sara Nejatinamini, and Dr. Vikki Ho. Dr. Dylan O’Sullivan is a Research Scientist at Alberta Health Services and an Adjunct Assistant Professor in the Cumming School of Medicine, Department of Community Health Sciences at the University of Calgary. His research interests include reducing the cancer burden across the full cancer control continuum (prevention, screening, and outcomes) with the use of existing methods and the development of novel data analytics. Dr. O’Sullivan will be presenting on the risk factors for early-onset colorectal cancer using CanPath data. Dr. Samina Abidi is an Associate Professor in the Department of Community Health and Epidemiology at the Faculty of Medicine at Dalhousie University and is cross appointed in the Faculty of Computer Science. Dr. Abidi has a unique skill set where she is a clinician with an expertise in health informatics. Her research interests include health knowledge integration, modelling and computerization, patient-centred care, chronic disease self-management and behaviour modification, clinical guidelines based clinical decision support and care planning, ambient assistant living, data visualizations, health IT evaluation. Dr. Abidi will be presenting on a digital health and artificial based public health platform for cancer risk prediction using data from Atlantic PATH.   Dr. Sara Nejatinamini is a Research Associate at Alberta’s Tomorrow Project. She received her PhD degree in Nutrition and Metabolism from the University of Alberta. Prior to joining the ATP, she undertook postdoctoral training at the University of Calgary with a focus on health inequities. Dr. Nejatinamini’s research interests include public health, nutrition and cancer. Her research focuses on the role of modifiable lifestyle factors on cancer and other chronic disease risk. She applies epidemiological and implementation science methods and principles in her research to identify factors to prevent cancer and other chronic diseases and inform health interventions. Dr. Nejatinamini will be presenting on changes in breast and cervical cancer screening during the COVID-19 pandemic using data from Alberta’s Tomorrow Project.  Dr. Vikki Ho is the co-Scientific Director of CARTaGENE and holds the Chair in Sex and Gender Sciences in Cancer Research from the Canadian Institutes of Health Research. She is an Assistant Professor in the Department of Social and Preventive Medicine in the School of Public Health (ESPUM) at the University of Montreal and a Researcher at the affiliated Hospital Research Centre (CRCHUM). Dr. Ho’s research interests focus on the intersection of environmental, lifestyle, occupational, and individual susceptibility factors in cancer etiology. Dr. Ho will be presenting on CARTaGENE’s research platform and the wide array of data sources for cancer prevention research, including environmental factors and biomarkers. She will specifically focus on occupational exposures and lung cancer biomarkers, and occupational exposures to endocrine disrupting chemicals and colorectal cancer risk. Dr. Ho will also present a poster on the CARTaGENE cohort. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST. 

Dr. Jennifer Brooks at #CCRC2023

Dr. Jennifer Brooks is the Executive Director of CanPath and an Assistant Professor in the Dalla Lana School of Public Health at the University of Toronto. Dr. Brooks’ research interests include breast cancer epidemiology, genetic epidemiology, imaging biomarkers of breast cancer risk and response to treatment; and survivorship.  Dr. Brooks will be attending the conference alongside two of her students, Shana Kim and Rebecca Christensen.  Shana Kim is a PhD candidate at the University of Toronto and a Research Coordinator at Women’s College Hospital. She will present her research on the association between pre-diagnostic routine lipid measurements and mortality among breast cancer survivors in the lightning session on Survivorship on Sunday, November 12th at 1:30pm.  Dr. Rebecca Christensen is a CIHR Postdoctoral Research Fellow at the University of Toronto. She will be presenting alongside Shana Kim in the lightning session on Survivorship on Sunday, November 12th at 1:30pm. Her research focuses on adherence to breast cancer screening guidelines and risk of breast cancer-specific death.   

Atlantic PATH (Cui & Sweeney) at #CCRC2023

Atlantic PATH will be well represented at the Canadian Cancer Research Conference. Yunsong Cui, MSc, is the Data Analyst at Atlantic PATH, Faculty of Medicine, Dalhousie University. He performs statistical analyses of health outcomes using data from Atlantic PATH, patient registries and administrative health databases. His primary research interests include physical activity, lifestyle, diet, and environmental factors related to cancer and comorbidities. His work at Atlantic PATH involves projects on cancer, inflammatory bowel disease, cardiovascular disease, environmental exposures, and polypharmacy.  Yunsong will be presenting a poster on depression, anxiety and the risk of cancer from the Psychosocial Factors and Cancer Incidence (PSY-CA) consortium, which includes data from 18 longitudinal cohorts in the Netherlands, United Kingdom and Canada, including Atlantic PATH, CARTaGENE (Quebec) and the Ontario Health Study (N=617,355).  Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST.  Yunsong will also present on the PSY-CA study in the lightning session in a panel on Cancer Risk and Primary Prevention on Tuesday, November 14 at 10:40am AST.  Dr. Ellen Sweeney is the Research Director at Atlantic PATH, Faculty of Medicine, Dalhousie University; Associate Member, Beatrice Hunter Cancer Research Institute; Affiliate Scientist, Nova Scotia Health; Scholar, Healthy Populations Institute, Dalhousie University; and Adjunct Professor, Faculty of Graduate Studies, Dalhousie University. Dr. Sweeney’s background is in environmental health and breast cancer. She is the primary contact for data access and leads the environmental and occupational health research streams at Atlantic PATH.   Dr. Sweeney will present a poster on exploring environmental exposure to arsenic and cancer risk in Atlantic PATH using toxicological and machine learning methods, as well as one on the mental health status of prostate cancer survivors in the Atlantic PATH cohort. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST. Dr. Sweeney will also present the mental health and prostate cancer study in the lightning session in a panel on Cancer Survivorship on Sunday, November 12th at 1:30pm.    

Dr. Robin Urquhart at #CCRC2023

Dr. Robin Urquhart is the co-chair of the Scientific Program Committee at the Canadian Cancer Research Conference. She is also the Scientific Director of Atlantic PATH; Canadian Cancer Society (Nova Scotia Division) Endowed Chair in Population Cancer Research; Associate Professor, Department of Community Health and Epidemiology, Dalhousie University; Senior Scientist, Beatrice Hunter Cancer Research Institute; and Affiliate Scientist, Nova Scotia Health. Dr. Urquhart’s research interests include access to and quality of cancer care, patient and family outcomes and experiences, and how to more effectively move research evidence into clinical practice and healthcare policy.   During the conference, Dr. Urquhart can be found:  At the Opening Remarks (Sunday, November 12th, 9am AST)  Chairing a session on the Crises Affecting Healthcare (Monday, November 13th at 11:40am AST)  At the Patient Engagement Workshop (Monday, November 13th at 4:40pm AST)  Chairing a session on environment and cancer with Patient Partner, Dr. Don Desserud (Tuesday, November 14th at 11:40am AST).   

Canadian Cancer Research Conference Community Event

CanPath and Atlantic PATH are excited to participate in the upcoming Community Event, “Cancer: Prevention, Treatment & You” at the Canadian Cancer Research Conference. Our team members are looking forward to meeting you!   Megan Fleming, Communications and Knowledge Translation Officer, CanPath  Jason Hicks, Executive Director, Atlantic PATH   Ellen Sweeney, Research Director, Atlantic PATH  This free event is open to the public:  Explore an exhibit hall with resources for people of all ages  Speak one-on-one with patient advocates  Learn about risk reduction  Get up-to-date information on screening and treatment, as well as helpful advice on life after a cancer diagnosis   Panel: Moderated by Eilish Bonang, Anchor of Global Morning News in Halifax, you will hear about interesting research from:  Dr. Nathalie Saint-Jacques, MSc, PhD, Senior Epidemiologist, Nova Scotia Health Cancer Care Program  Dr Michael N. Ha, MD, PhD, FRCPC, Radiation Oncologist, Nova Scotia Health  Mr. Tom Christensen, MSc, Clinical Exercise Physiologist (CSEP-CEP), Physical Activity and Cancer (PAC) Lab   Details:   Saturday, November 11th   1:30-4:30pm AST  Halifax Convention Centre: Argyle Suite  1650 Argyle Street, Halifax 

CanPath and Regional Cohorts at the Canadian Cancer Research Conference (#CCRC2023)

CanPath and its regional cohorts will be well represented at the upcoming Canadian Cancer Research Conference in Halifax on November 11-14th. This conference is hosted by the Canadian Cancer Research Alliance. It brings together the Canadian cancer research community and spans the research spectrum.   We’re pleased to have attendees from the CanPath National Coordinating Centre and regional cohorts including Atlantic PATH, CARTaGENE (Quebec), the Ontario Health Study, the Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and the BC Generations Project.   Over the next two weeks, we will share more details about where to find CanPath and regional cohort representatives at the conference (e.g., plenaries, concurrent and lightning sessions, poster presentations, etc.), as well as researchers who have used data and biological samples from CanPath and the regional cohorts. Stay tuned! 

Pan-Canadian Cancer Data Strategy

The Canadian Cancer Society (CCS) and Canadian Partnership Against Cancer (CPAC) have launched the Pan-Canadian Cancer Data Strategy that will guide efforts to enhance the collection, integration and use of cancer data. “CPAC and CCS have worked with various partners, including provincial and territorial cancer agencies and programs, healthcare organizations, First Nations, Inuit and Métis partners, researchers, policymakers and people with lived cancer experience to create a cancer-specific data strategy that includes: a framework to guide the mission, vision, values and success factors for improvements in cancer data three priorities for action and investment including: improving the efficiency, timeliness and quality of data capture and access enhancing linkages to current data filling gaps in current data collection and availability a section on the importance of First Nations, Inuit and Métis data sovereignty, with examples of First Nations, Inuit and Métis-led efforts to improve data and data governance.” CanPath, and its seven regional cohorts including Atlantic PATH, are proud to be represented in the new Pan-Canadian Cancer Data Strategy.  We’re committed to filling gaps in data on risk factors to guide cancer prevention efforts.  CPAC Press Release: https://www.partnershipagainstcancer.ca/about-us/corporate-resources-publications/pan-canadian-cancer-data-strategy/

Join us in Halifax — CCRA Call for Abstracts

The Canadian Cancer Research Conference provides an excellent opportunity to present research to the cancer community. Abstract submissions from the entire spectrum of research topics are welcome. Abstract submission for the 2023 Canadian Cancer Research Conference is now open.  Abstract submission deadline: Friday, June 9, 2023 at 11:59 PM (midnight) EDT Abstract submissions from the entire spectrum of cancer research topics are welcome. The online abstract submission process is bilingual. Abstract submissions will be accepted in both English and French. Abstracts will appear in the language of submission, and posters may be prepared and presented orally in the presenter’s language of choice. Please note all lightning and oral presenters must present in person at the 2023 CCRC in Halifax. Additional details: https://www.ccra-acrc.ca/conference/abstracts/